Experimental transplant arteriosclerosis: inhibition by angiopeptin and low molecular weight heparin derivatives.
Department of Pathology, University Hospital, Uppsala, Sweden.
M L
ML
Akyürek
E
E
Larsson
K
K
Funa
A
A
Wanders
M
M
Kaijser
B C
BC
Fellström
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000473:pathology / Q000637:transplantation*; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000473:pathology; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D009842:Oligopeptides / Q000494:pharmacology*; D010456:Peptides, Cyclic; D051381:Rats; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D002317:Cardiovascular Agents; D006495:Heparin, Low-Molecular-Weight; D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin